FDA

FDA Articles

ThinkstockMerck & Co. Inc. (NYSE: MRK) is seeing one more drug drive off the patent cliff. News was released on Monday by Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) that it and Perrigo Co....
ThinkstockThe war against Alzheimer’s disease is getting another round of stem cell research thrown at it. While this involves a public company, the reality is that Alzheimer’s is truly a holy...
courtesy of NBN at German WikipediaThe news around tobacco and smoking cigarettes has been dominated by the trends around the e-cigarette market in 2013, but perhaps something else is afoot here....
ThinkstockThe world of biotech investing is always a difficult one. Often a binary event, such as a Food and Drug Administration (FDA) approval or a life-saving capital raise, is the difference...
ThinkstockA new communication has been issued by the U.S. Food & Drug Administration (FDA) for medical device manufacturers. This may sound like it is out of a science fiction movie, but the...
Jon OggChelsea Therapeutics International Ltd. (NASDAQ: CHTP) is rallying on Wednesday after a report in Seeking Alpha called its Northera, a treatment for symptomatic neurogenic hypotension in...
ThinkstockThe U.S. Food and Drug Administration (FDA) last night rejected an application from Johnson & Johnson (NYSE: JNJ) and Germany’s Bayer A.G. to extend the use of the two companies’...
ThinkstockArena Pharmaceuticals Inc. (NASDAQ: ARNA) is posing yet one more threat to ambitious biotechs and drug-makers who are targeting the obesity market. Its stock is getting slapped by almost...
ThinkstockAfter a strong year of relative performance for pharmaceutical stocks in 2012, the analysts at Jefferies Group Inc. (NYSE: JEF) predict that 2013 could show more of the same. However they...
ThinkstockBack in December, we took an in-depth look at what has become a crowded race in the obesity drug market. As we pointed out then, the race has become a battle of not only who has the drug...
ThinkstockAccording to the Centers for Disease Control (CDC), more than one-third (35.7%) of all adults in the United States are obese. Obesity-related medical conditions include heart attack,...
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) was halted today for news that the company’s weight-loss drug called BELVIQ has been approved.  The news is good for all obesity drug makers today. ...
This last week marked another solid week for investors and many stocks were on the move.  We have compiled a list of stocks we are looking for event-driven trading moves in the coming week that are...
Taxpayers are more on guard about what the federal government spends than they have been in years, or perhaps longer, as threats of a high deficit and national debt highlight concerns about a drop in...
The food industry has decided to set up its own nutrition labeling system. The President’s wife and FDA wanted the federal government do this. The Grocery Manufacturers Association, which...